As of November 2024, Hubei Goto Biopharm has a market cap of $228.26M. This makes Hubei Goto Biopharm the world's 16505th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $223.37M | -40.27% |
2023 | $373.97M | -14.93% |
2022 | $439.58M | -34.18% |
2021 | $667.84M | - |